These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1009 related articles for article (PubMed ID: 19595395)

  • 1. In-hospital complications and long-term outcomes of the paclitaxel drug-eluting stent in acute ST-elevation myocardial infarction: a real-world experience from a high-volume medical center.
    Shammas NW; Shammas GA; Hahn A; Jerin M; Dippel EJ; Winter M
    Cardiovasc Revasc Med; 2009; 10(3):151-5. PubMed ID: 19595395
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drug-eluting stents are associated with similar cardiovascular outcomes when compared to bare metal stents in the setting of acute myocardial infarction.
    Slottow TL; Steinberg DH; Roy P; Javaid A; Buch AN; Okabe T; Xue Z; Smith K; Torguson R; Pichard AD; Satler LF; Suddath WO; Kent KM; Waksman R
    Cardiovasc Revasc Med; 2008; 9(1):24-8. PubMed ID: 18206634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Drug-eluting stent thrombosis in routine clinical practice: two-year outcomes and predictors from the TAXUS ARRIVE registries.
    Lasala JM; Cox DA; Dobies D; Baran K; Bachinsky WB; Rogers EW; Breall JA; Lewis DH; Song A; Starzyk RM; Mascioli SR; Dawkins KD; Baim DS;
    Circ Cardiovasc Interv; 2009 Aug; 2(4):285-93. PubMed ID: 20031730
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of left main coronary trifurcation lesions with the paclitaxel drug-eluting stent: mid-term outcomes from a tertiary medical center.
    Shammas NW; Shammas GA; Jerin M; Parikh A; Coin K; Dippel E; Sharis P; Robken J
    J Invasive Cardiol; 2009 Jul; 21(7):321-5. PubMed ID: 19571341
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Long-term paclitaxel-eluting stent outcomes in elderly patients.
    Forman DE; Cox DA; Ellis SG; Lasala JM; Ormiston JA; Stone GW; Turco MA; Wei JY; Joshi AA; Dawkins KD; Baim DS
    Circ Cardiovasc Interv; 2009 Jun; 2(3):178-87. PubMed ID: 20031714
    [TBL] [Abstract][Full Text] [Related]  

  • 6. One-year outcomes with the Taxus Liberté stent in the real world: the Taxus Olympia registry (phase I).
    Ahmed WH; Zambahari R; Al-Rashdan I; Al Naeemi A; Saeed FA; Mascioli S
    J Interv Cardiol; 2008 Dec; 21(6):512-8. PubMed ID: 18973513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Paclitaxel-eluting versus bare-metal stents in acute ST elevation myocardial infarction (STEMI).
    Hamirani YS; Jibrin I; Abraham D; Merriman B; Wenz C; Bahr RD
    Crit Pathw Cardiol; 2008 Dec; 7(4):232-8. PubMed ID: 19050419
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical safety and efficacy of a novel thin-strut cobalt-chromium coronary stent system: results of the real world Coroflex Blue Registry.
    Bocksch W; Pomar F; Dziarmaga M; Tresukosol D; Ismail O; Janek B; Carlsson J; Simon JP;
    Catheter Cardiovasc Interv; 2010 Jan; 75(1):78-85. PubMed ID: 19739262
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes after differential use of drug-eluting stents in diabetic patients: 1-year results from the DES.DE (Drug-Eluting Stent.DEutschland) registry.
    Akin I; Bufe A; Eckardt L; Reinecke H; Richardt G; Kuck KH; Senges J; Schneider S; Nienaber CA;
    Catheter Cardiovasc Interv; 2010 Jul; 76(1):50-7. PubMed ID: 20578192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical impact of sirolimus-eluting stent in ST-segment elevation myocardial infarction: a meta-analysis of randomized clinical trials.
    Piscione F; Piccolo R; Cassese S; Galasso G; Chiariello M
    Catheter Cardiovasc Interv; 2009 Aug; 74(2):323-32. PubMed ID: 19360858
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drug-eluting stents versus bare-metal stents in acute ST-segment elevation myocardial infarction. a single-center experience with long-term follow up.
    Palmieri C; Ravani M; Trianni G; Gianetti J; Vaghetti M; Rizza A; Paradossi U; Beqiri A; Berti S
    J Invasive Cardiol; 2010 Apr; 22(4):151-8. PubMed ID: 20351384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drug-eluting stents in the elderly: long-term (> one year) clinical outcomes of octogenarians in the DESIRE (Drug-Eluting Stents In the REal world) registry.
    Costa JR; Sousa A; Moreira AC; Costa RA; Maldonado G; Cano MN; Egito ET; Romano ER; Barbosa M; Pavanello R; Jardim C; Cury A; Berwanger O; Sousa JE
    J Invasive Cardiol; 2008 Aug; 20(8):404-10. PubMed ID: 18688065
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 5-year follow-up after primary percutaneous coronary intervention with a paclitaxel-eluting stent versus a bare-metal stent in acute ST-segment elevation myocardial infarction: a follow-up study of the PASSION (Paclitaxel-Eluting Versus Conventional Stent in Myocardial Infarction with ST-Segment Elevation) trial.
    Vink MA; Dirksen MT; Suttorp MJ; Tijssen JG; van Etten J; Patterson MS; Slagboom T; Kiemeneij F; Laarman GJ
    JACC Cardiovasc Interv; 2011 Jan; 4(1):24-9. PubMed ID: 21251625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical outcomes after sirolimus-eluting, paclitaxel-eluting, and bare metal stents (from the first phase of the prospective multicenter German DES.DE Registry).
    Nienaber CA; Akin I; Schneider S; Senges J; Fetsch T; Tebbe U; Willich SN; Stumpf J; Sabin GV; Silber S; Richardt G; Kuck KH;
    Am J Cardiol; 2009 Nov; 104(10):1362-9. PubMed ID: 19892051
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical outcomes of dexamethasone-eluting stent implantation in ST-elevation acute myocardial infarction.
    Jimenez-Valero S; Santos B; Pajin F; Canton T; Lazaro E; Moreu J; Hernandez G; Padial LR
    Catheter Cardiovasc Interv; 2007 Oct; 70(4):492-7. PubMed ID: 17896411
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Usage patterns and 2-year outcomes with the TAXUS express stent: results of the US ARRIVE 1 registry.
    Lasala JM; Cox DA; Dobies D; Muhlestein JB; Katopodis JN; Revtyak G; Baim DS;
    Catheter Cardiovasc Interv; 2008 Oct; 72(4):433-45. PubMed ID: 18814217
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-term outcomes in treating left main trifurcation coronary artery disease with the Paclitaxel-eluting stent.
    Shammas NW; Dippel EJ; Avila A; Gehbauer L; Farland L; Brosius S; Jerin M; Winter M; Stoakes P; Byrd J; Majetic L; Shammas G; Sharis P; Robken J
    J Invasive Cardiol; 2007 Feb; 19(2):77-82. PubMed ID: 17268042
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Outcomes of the tacrolimus drug-eluting Janus stent: a prospective two-centre registry in high-risk patients.
    Romagnoli E; Leone AM; Burzotta F; Trani C; Angeloni G; Materazzo G; Niccoli G; De Vita M; Perfetti M; Mazzari MA; Mongiardo R; Rebuzzi AG; Schiavoni G; Crea F
    J Cardiovasc Med (Hagerstown); 2008 Jun; 9(6):589-94. PubMed ID: 18475127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Percutaneous coronary intervention utilizing a new endothelial progenitor cells antibody-coated stent: a prospective single-center registry in high-risk patients.
    Miglionico M; Patti G; D'Ambrosio A; Di Sciascio G
    Catheter Cardiovasc Interv; 2008 Apr; 71(5):600-4. PubMed ID: 18360849
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug-eluting stent implantation in ST-elevation acute myocardial infarction: 'real world' 30-day and mid-term results.
    Novaro GM; Cherla A; Fromkin KR; Bush HS
    Cardiovasc Revasc Med; 2007; 8(1):5-8. PubMed ID: 17293262
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 51.